Cascades Announces License of Mobile Health Diagnostics Portfolio
Cascades Ventures is pleased to announce a non-exclusive license of PTS Diagnostics' Mobile Health Diagnostics patent portfolio. The key patents cover a Mobile Analyte Testing Device which uses a smartphone camera to detect analytes on a test strip. The portfolio includes 27 total assets across two patent families, with both US and international coverage. Terms of the deal are confidential.
"Medical diagnostics that can be performed using a smartphone is a rapidly expanding area of technology," said Cascades' Director Mark Magas. "The PTS Mobile Health Diagnostics patent portfolio is a seminal portfolio developed by prolific inventor Hans G. Kloepfer. The technology is starting to gain widespread adoption by many major healthcare companies and this portfolio provides strong protection."
The Mobile Health Diagnostics portfolio is still available for license or sale. If you are interested, please contact us here: https://cascadesventures.com/contact.
About PTS Diagnostics. PTS Diagnostics is an innovative point-of-care diagnostics solutions provider that partners with patients and healthcare professionals to provide the right information at the right time to make the right decisions. For more information, visit https://ptsdiagnostics.com/.
About Cascades Ventures. Cascades Ventures is a leading patent brokerage and enforcement firm with over twenty years of experience monetizing patents. For more information, visit https://cascadesventures.com.
To view all of our patent portfolios currently on offer, visit https://cascadesventures.com/portfolios.